5-Bromo-2-methylpyrimidine → HCID 16117316, compound
Reaction equation
Cl[C:2]1[C:11]2[N:10]=[C:9]([CH3:12])[CH:8]=[CH:7][C:6]=2[C:5](B(O)O)=[CH:4][N:3]=1.Br[C:17]1[CH:18]=[N:19][C:20]([CH3:23])=[N:21][CH:22]=1.[NH2:24][C:25]1[N:26]=[C:27]([CH3:30])[S:28][CH:29]=1>>[CH3:12][C:9]1[CH:8]=[CH:7][C:6]2[C:11](=[C:2]([NH:24][C:25]3[N:26]=[C:27]([CH3:30])[S:28][CH:29]=3)[N:3]=[CH:4][C:5]=2[C:17]2[CH:18]=[N:19][C:20]([CH3:23])=[N:21][CH:22]=2)[N:10]=1Participants
4
Procedure
The title compound, MS: m/e=349.2 (M+H+), was prepared in accordance with the general method of example 15 step 1 and step 3 from 8-chloro-2-methyl-[1,7]naphthyridine-5-boronic acid (Example L), 5-bromo-2-methylpyrimidine and 4-amino-2-methylthiazole (Example F).
Sources & evidence
- ORD record
- ord-93418a0b20b74152a9703a735a9b061b
- Source dataset
- uspto-grants-2009_03
- Patent number
- US07511055B2
Reaction notes
Loading…